Mapping Biological Complexity
Chris discusses the varying complexities in understanding different areas of biology, highlighting genetic diseases and cancers as more straightforward compared to the challenges posed by neurological disorders like Alzheimer's. He emphasizes the importance of partnerships with leading biopharma companies to map genomes in neural cells, paving the way for deeper insights. The conversation also touches on the technological advancements that have led to the development of Bio Hive Two, showcasing the ever-increasing data and computational demands in the field.In this clip
From this podcast
The AI Podcast
Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
Related Questions